Literature DB >> 7139200

The effects of amfonelic acid and some other central stimulants on mouse striatal tyramine, dopamine and homovanillic acid.

A V Juorio.   

Abstract

1 The concentrations of p- and m-tyramine, dopamine and homovanillic acid were measured in the mouse striatum following the subcutaneous administration of amfonelic acid, (+)-amphetamine or nomifensine.2 The administration of 2.5-25 mg/kg of amfonelic acid produced a reduction in p-tyramine that lasted at least 8 h. m-Tyramine was significantly increased and this was observed between 2 and 24 h after drug treatment. The levels of homovanillic acid were increased within 4 h after amfonelic acid administration.3 (+)-Amphetamine treatment (5 mg/kg) produced a reduction in p-tyramine observed up to 4 h after its administration and no significant changes in m-tyramine.4 The administration of 10 mg/kg of nomifensine produced no significant changes in p-tyramine, m-tyramine or homovanillic acid. By increasing the dose to 20 mg/kg, nomifensine produced an increase in p-tyramine and homovanillic acid.5 The present results support the view that amfonelic acid and (+)-amphetamine would respectively release granular or newly synthesized dopamine, both actions being accompanied by an increase in tyrosine hydroxylase activity and dopamine turnover which in turn reduces p-tyramine but produces no change or an increase in m-tyramine.6 The effects of nomifensine were observed after the administration of a relatively high dose (20 mg/kg), that was lethal to some mice (about 20%, at 2 h), and more likely to posses unspecific actions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7139200      PMCID: PMC2044633          DOI: 10.1111/j.1476-5381.1982.tb09325.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Effect of chlorpromazine and other anti-psychotic drugs on mouse striatal tyramines.

Authors:  A V Juorio
Journal:  Life Sci       Date:  1977-05-15       Impact factor: 5.037

2.  Effects of D-amphetamine and antipsychotic drug administration on striatal tyramine levels in the mouse.

Authors:  A V Juorio
Journal:  Brain Res       Date:  1977-04-22       Impact factor: 3.252

3.  Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron.

Authors:  P A Shore
Journal:  J Pharm Pharmacol       Date:  1976-11       Impact factor: 3.765

4.  Effect of acute and chronic injections of amphetamine on intracranial self-stimulation (ICS) and some aryl alkyl amines and the rat brain.

Authors:  T J Danielson; T B Wishart; A A Boulton
Journal:  Life Sci       Date:  1976-06-01       Impact factor: 5.037

5.  Effect of nomifensine on motor activity, dopamine turnover rate and cyclic 3',5;-adenosine monophosphate concentrations of rat striatum.

Authors:  H J Gerhards; A Carenzi; E Costa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Identification and distribution of p-tyramine in the rat.

Authors:  S R Philips; D A Durden; A A Boulton
Journal:  Can J Biochem       Date:  1974-05

7.  Enhancement of tyrosine hydroxylation within the brain by chlorpromazine.

Authors:  G Bartholini; A Pletscher
Journal:  Experientia       Date:  1969-09-15

8.  Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum.

Authors:  P Hunt; M Kannengiesser; J Raynaud
Journal:  J Pharm Pharmacol       Date:  1974-05       Impact factor: 3.765

9.  Identification and distribution of m-tyramine in the rat.

Authors:  S R Philips; B A Davis; D A Durden; A A Boulton
Journal:  Can J Biochem       Date:  1975-01

10.  The effects of reserpine and 6-hydroxydopamine on the concentrations of some arylakylamines in rat brain.

Authors:  A A Boulton; A V Juorio; S R Philips; P H Wu
Journal:  Br J Pharmacol       Date:  1977-01       Impact factor: 8.739

View more
  1 in total

Review 1.  [Central nervous system side effects of different antibacterial substances].

Authors:  G Stoppe; E Rüther
Journal:  Infection       Date:  1991       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.